We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+9.13%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$20.5B
AUM Growth
+$1.31B
Cap. Flow
-$64.5M
Cap. Flow %
-0.31%
Top 10 Hldgs %
30.13%
Holding
1,270
New
254
Increased
410
Reduced
389
Closed
206

Top Sells

Rank Stock Value
1
RY icon
Royal Bank of Canada
RY
+$115M
2
ENB icon
Enbridge
ENB
+$87.8M
3
PFE icon
Pfizer
PFE
+$80.4M
4
CNI icon
Canadian National Railway
CNI
+$78.6M
5
AAPL icon
Apple
AAPL
+$73.1M

Sector Composition

Rank Sector Weight
1 Financials 24.6%
2 Technology 17.8%
3 Industrials 12.95%
4 Communication Services 8.37%
5 Materials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPZM
1001
DELISTED
Epizyme, Inc
EPZM
$161K ﹤0.01%
+64,493
New +$253K
CSLT
1002
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$161K ﹤0.01%
104,345
-51,655
-33% -$85.2K
UEC icon
1003
Uranium Energy
UEC
$5.5B
$159K ﹤0.01%
47,327
-46,460
-50% -$179K
PRVB
1004
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$157K ﹤0.01%
27,864
-20,619
-43% -$131K
GFI icon
1005
Gold Fields
GFI
$35.2B
$156K ﹤0.01%
+14,172
New +$141K
LPG icon
1006
Dorian LPG
LPG
$1.98B
$153K ﹤0.01%
12,030
-14,202
-54% -$180K
RDUS
1007
DELISTED
Radius Health, Inc.
RDUS
$152K ﹤0.01%
+21,966
New +$322K
PASG icon
1008
Passage Bio
PASG
$14.8M
$148K ﹤0.01%
+1,166
New +$190K
UBX
1009
DELISTED
Unity Biotechnology
UBX
$138K ﹤0.01%
+9,428
New +$206K
FRBK
1010
DELISTED
Republic First Bancorp Inc
FRBK
$136K ﹤0.01%
+36,663
New +$123K
CAMP
1011
DELISTED
CalAmp Corp.
CAMP
$135K ﹤0.01%
+830
New +$184K
OPBK icon
1012
OP Bancorp
OPBK
$237M
$134K ﹤0.01%
+10,532
New +$127K
TCRR
1013
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$134K ﹤0.01%
28,760
+4,443
+18% +$27.8K
CTG
1014
DELISTED
Computer Task Group, Inc.
CTG
$131K ﹤0.01%
13,137
-598
-4% -$5.05K
USX
1015
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$130K ﹤0.01%
+22,167
New +$166K
IVC
1016
DELISTED
Invacare Corporation
IVC
$130K ﹤0.01%
+47,795
New +$176K
PZN
1017
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$126K ﹤0.01%
13,259
+1,354
+11% +$14.1K
RJET
1018
Republic Airways Holdings
RJET
$957M
$125K ﹤0.01%
1,483
+134
+10% +$14.6K
CPSS icon
1019
Consumer Portfolio Services
CPSS
$206M
$123K ﹤0.01%
10,372
-3,079
-23% -$23.8K
BBAR icon
1020
BBVA Argentina
BBAR
$3.19B
$122K ﹤0.01%
38,635
-39,146
-50% -$139K
LVO icon
1021
LiveOne
LVO
$57.7M
$121K ﹤0.01%
9,482
-7,015
-43% -$154K
TAST
1022
DELISTED
Carrols Restaurant Group, Inc.
TAST
$120K ﹤0.01%
40,571
-52,737
-57% -$177K
RLX icon
1023
RLX Technology
RLX
$2.47B
$119K ﹤0.01%
+30,393
New +$140K
AXIA
1024
DELISTED
AXIA Energia
AXIA
$118K ﹤0.01%
24,473
+8,935
+58% +$44.9K
ATNX
1025
DELISTED
Athenex, Inc. Common Stock
ATNX
$113K ﹤0.01%
4,165
+199
+5% +$8.4K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q4 2021 Portfolio in Review

As of Q4 2021, Connor, Clark & Lunn Investment Management (CC&L) held 1,270 positions worth $20.5B, up 6.8% from $19.2B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L)'s Q4 2021 filing shows 254 new, 410 increased, 389 reduced and 206 closed positions. Its largest new stake was Nuvei Corporation Subordinate Voting Shares: 879,610 shares worth $57.1M. The largest sale was Royal Bank of Canada, an estimated $115M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q4 2021 buy was Nuvei Corporation Subordinate Voting Shares: 879,610 shares worth $57.1M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Waste Connections in Q4 2021, an estimated $102M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q4 2021 reduction was Royal Bank of Canada, cutting an estimated $115M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Edwards Lifesciences in Q4 2021, selling an estimated $26.6M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 30% of its $20.5B portfolio in Q4 2021.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 254 new positions and closed 206 in Q4 2021.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 6.8% quarter-over-quarter to $20.5B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2021, filed 10 Feb 2022.